News

The American Liver Foundation (ALF) has brought its “Bili the Brave” children’s book to life with a new animated video that aims to support…

One-time treatment with VRON-0200 reduced hepatitis B virus (HBV) levels in the blood of most people with chronic hepatitis B — early trial findings…

People with primary biliary cholangitis (PBC) who don’t start treatment after being diagnosed with the liver disease end up hospitalized more often and for…

Progressive familial intrahepatic cholestasis type 3 (PFIC3) can cause abnormalities in copper metabolism that mimic another condition, Wilson’s disease, and early distinction is key…

A new add-on blood test called the FAP-Index may help accurately identify serious liver scarring in people with metabolic dysfunction-associated steatotic liver disease (MASLD),…

Livmarli (maralixibat) successfully cleared rare, debilitating fatty skin growths and eased chronic itching in two young boys with Alagille syndrome in the U.S., according…

Efforts to eliminate new hepatitis C cases by 2030, a goal set by the World Health Organization (WHO), are falling short in high-risk groups,…

Primary sclerosing cholangitis (PSC) patients with inflammatory bowel disease (IBD) face a higher risk of liver-related complications and the need for a liver transplant…

Volixibat, Mirum Pharmaceuticals’ experimental oral treatment, may help reduce circulating bile acids and ease itch in pregnant women with intrahepatic cholestasis of pregnancy…

Daily treatment with Orsobio’s oral candidate TLC-2716 reduces fat levels in both the blood and liver in overweight adults with high blood fat levels…